- B2B
- Early StageStartup in initial stages
EDP Biotech Funding
$25M
22 rounds
EDP Biotech is active in the following markets / industries: South Korea and Europe. The company has secured funding across 2 rounds and is valued at $25M. Their most recent funding was raised on March 1, 2018.
Funding Rounds
CLO
$950000S
$16000000Investors of EDP Biotech
Eric Mayer
CEO of EDP Biotech • Worked at @BioPet Vet Labs • Investor @EDP Biotech
